Now accepting pre-proposal applications for Columbia Life Science Accelerator Program - Due Monday, Nov. 20

September 24, 2020

We are pleased to introduce the 2020-2021 cycle of the Columbia Life Science Accelerator Programs (BioMedX, TRx, and ACT). Pre-proposal applications can be submitted via a single application form at https://ColumbiaLSA.submittable.com by Monday, November 20th at 5:00PM EST.

The Columbia L2M Life Science Accelerator programs help translate cutting-edge faculty-led university research out of the lab through project funding, education, and support for interdisciplinary teams working to advance innovative ideas with the potential to positively impact health outcomes.

The three core accelerators center on:

Therapeutics/Drug Development

Accelerating Cancer Therapeutics | ACT | Questions? Contact act@cumc.columbia.edu

Translational Therapeutics Resource | TRx | Questions? Contact TRxResource@columbia.edu

Medical Devices/Technologies/Software

Biomedical Engineering Technology Accelerator | BioMedX | Questions? Contact BiomedX@columbia.edu

 

For additional information, please register for one of our upcoming virtual informational sessions at: 

  • Tuesday, September 22nd, 3:30 – 4:30PM EST
  • Monday, October 26th, 2:00 – 3:00PM EST
  • Wednesday, November 18th, 12:00 – 1:00PM EST

Topics

Education, Research, Data Science, Funding, Translational Therapeutics